These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27716027)

  • 1. Identification of gene-drug interactions that impact patient survival in TCGA.
    Spainhour JC; Qiu P
    BMC Bioinformatics; 2016 Oct; 17(1):409. PubMed ID: 27716027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDISC: a web portal for integrative analysis of gene-drug interaction for survival in cancer.
    Spainhour JCG; Lim J; Qiu P
    Bioinformatics; 2017 May; 33(9):1426-1428. PubMed ID: 28453687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.
    Jones DC; Scanteianu A; DiStefano M; Bouhaddou M; Birtwistle MR
    PLoS One; 2018; 13(1):e0190664. PubMed ID: 29342193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
    Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
    Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for generating new datasets based on copy number for cancer analysis.
    Kim S; Kon M; Kang H
    Biomed Res Int; 2015; 2015():467514. PubMed ID: 25949998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering key regulatory mechanisms from single-factor and multi-factor regulations in glioblastoma utilizing multi-dimensional data.
    Peng C; Shen Y; Ge M; Wang M; Li A
    Mol Biosyst; 2015 Aug; 11(8):2345-53. PubMed ID: 26091184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
    Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
    Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models.
    Zheng X; Amos CI; Frost HR
    BMC Bioinformatics; 2020 Oct; 21(1):467. PubMed ID: 33081688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIOFILTER AS A FUNCTIONAL ANNOTATION PIPELINE FOR COMMON AND RARE COPY NUMBER BURDEN.
    Kim D; Lucas A; Glessner J; Verma SS; Bradford Y; Li R; Frase AT; Hakonarson H; Peissig P; Brilliant M; Ritchie MD
    Pac Symp Biocomput; 2016; 21():357-68. PubMed ID: 26776200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy Number Alterations in Tumor Genomes Deleting Antineoplastic Drug Targets Partially Compensated by Complementary Amplifications.
    Tran HV; Kiemer AK; Helms V
    Cancer Genomics Proteomics; 2018; 15(5):365-378. PubMed ID: 30194077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Web-TCGA: an online platform for integrated analysis of molecular cancer data sets.
    Deng M; Brägelmann J; Schultze JL; Perner S
    BMC Bioinformatics; 2016 Feb; 17():72. PubMed ID: 26852330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
    Huang T; Yang J; Cai YD
    Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals.
    Ping Y; Zhang H; Deng Y; Wang L; Zhao H; Pang L; Fan H; Xu C; Li F; Zhang Y; Gong Y; Xiao Y; Li X
    Mol Biosyst; 2014 Aug; 10(8):2031-42. PubMed ID: 24911613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content.
    Kling T; Johansson P; Sanchez J; Marinescu VD; Jörnsten R; Nelander S
    Nucleic Acids Res; 2015 Sep; 43(15):e98. PubMed ID: 25953855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
    Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
    Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
    Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of rare germline copy number variations over-represented in five human cancer types.
    Park RW; Kim TM; Kasif S; Park PJ
    Mol Cancer; 2015 Feb; 14():25. PubMed ID: 25644941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.